Arrowhead Pharmaceuticals Funding: $60M Raised, IPO

Arrowhead Pharmaceuticals is based in Pasadena, CA. It has raised $60M in total funding. Latest round: IPO. Backed by Silence Therapeutics.

Arrowhead Pharmaceuticals funding overview

Arrowhead Pharmaceuticals is based in Pasadena, CA. Arrowhead Pharmaceuticals has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is an IPO. Investors on record include Silence Therapeutics.

Arrowhead Pharmaceuticals at a glance

Total raised
$60M
Latest round
IPO
Headquarters
Pasadena, CA
Notable investors
Silence Therapeutics

Frequently asked about Arrowhead Pharmaceuticals funding

How much has Arrowhead Pharmaceuticals raised?
Arrowhead Pharmaceuticals has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Arrowhead Pharmaceuticals?
Silence Therapeutics are named among the investors backing Arrowhead Pharmaceuticals.
What was the latest Arrowhead Pharmaceuticals funding round?
The most recent disclosed round is an IPO.
Where is Arrowhead Pharmaceuticals based?
Arrowhead Pharmaceuticals is based in Pasadena, CA.

Arrowhead Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Pasadena below to benchmark round size and investor mix.

Companies related to Arrowhead Pharmaceuticals (15)

Browse related funding lists (2)

Company funding database · Investor directory · Founder database · Mega-rounds 2026